Incidental Mutation 'R1499:Glb1'
ID 168707
Institutional Source Beutler Lab
Gene Symbol Glb1
Ensembl Gene ENSMUSG00000045594
Gene Name galactosidase, beta 1
Synonyms Bgl-s, Bgl, C130097A14Rik, Bge, Bgl-t, Bgl-e, Bgs, Bgt
MMRRC Submission 039550-MU
Accession Numbers
Essential gene? Non essential (E-score: 0.000) question?
Stock # R1499 (G1)
Quality Score 225
Status Validated
Chromosome 9
Chromosomal Location 114230146-114303447 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) A to G at 114246171 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Lysine to Arginine at position 74 (K74R)
Ref Sequence ENSEMBL: ENSMUSP00000055803 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000063042] [ENSMUST00000217583]
AlphaFold P23780
Predicted Effect probably benign
Transcript: ENSMUST00000063042
AA Change: K74R

PolyPhen 2 Score 0.035 (Sensitivity: 0.94; Specificity: 0.82)
SMART Domains Protein: ENSMUSP00000055803
Gene: ENSMUSG00000045594
AA Change: K74R

DomainStartEndE-ValueType
signal peptide 1 24 N/A INTRINSIC
Pfam:Glyco_hydro_35 41 358 2.5e-129 PFAM
Pfam:Glyco_hydro_42 56 216 9.4e-15 PFAM
Pfam:BetaGal_dom4_5 531 623 4.3e-10 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000217583
Meta Mutation Damage Score 0.1324 question?
Coding Region Coverage
  • 1x: 99.1%
  • 3x: 98.3%
  • 10x: 96.4%
  • 20x: 93.4%
Validation Efficiency 99% (83/84)
MGI Phenotype FUNCTION: This gene encodes a preproprotein that is proteolytically cleaved to yield a signal peptide and a proproptein that is subsequently processed to generate the active mature peptide. The encoded protein is a lysosomal enzyme that catalyzes the hydrolysis of terminal beta-D-galactose residues in various substrates like lactose, ganglioside GM1 and other glycoproteins. Mutations in the human gene are associated with GM1-gangliosidosis and Morquio B syndrome. Disruption of the mouse gene mirrors the symptoms of human gangliosidosis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]
PHENOTYPE: Homozygotes for a targeted null mutation exhibit progressive spastic diplegia, emaciation, and accumulation of ganglioside GM1 and asialo GM1 in brain tissue. Mutants die at 7-10 months of age. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 81 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Abca9 T A 11: 110,030,458 (GRCm39) Y763F probably benign Het
Abcb10 C T 8: 124,688,791 (GRCm39) G495D probably damaging Het
Actl11 A G 9: 107,808,682 (GRCm39) T1002A probably damaging Het
Ampd1 T A 3: 102,998,980 (GRCm39) N378K probably damaging Het
Arhgap42 A G 9: 9,033,587 (GRCm39) probably benign Het
Arhgap6 C A X: 167,579,499 (GRCm39) P95T possibly damaging Het
Atg14 T C 14: 47,798,102 (GRCm39) N87S probably benign Het
Atp9b C T 18: 80,805,353 (GRCm39) C735Y probably damaging Het
Atp9b T A 18: 80,822,122 (GRCm39) T110S probably benign Het
Birc6 T G 17: 74,919,314 (GRCm39) L221R probably damaging Het
Ces1c A G 8: 93,854,233 (GRCm39) F101L probably benign Het
Cfap91 A G 16: 38,141,762 (GRCm39) V390A probably damaging Het
Chsy1 T C 7: 65,821,750 (GRCm39) Y662H probably damaging Het
Cldn12 A T 5: 5,557,900 (GRCm39) F176I probably benign Het
Col5a2 A G 1: 45,450,626 (GRCm39) S374P probably benign Het
Col6a2 A T 10: 76,439,544 (GRCm39) V740E probably damaging Het
Cpne3 A T 4: 19,526,336 (GRCm39) I401K probably damaging Het
Cspp1 T A 1: 10,159,191 (GRCm39) probably null Het
Ddn G A 15: 98,704,647 (GRCm39) T215I possibly damaging Het
Dync1i1 T C 6: 5,769,799 (GRCm39) probably benign Het
Dync2li1 T C 17: 84,954,667 (GRCm39) probably benign Het
Eif2a T A 3: 58,445,005 (GRCm39) L50* probably null Het
Elavl3 G A 9: 21,929,875 (GRCm39) A343V probably damaging Het
Fastkd1 T C 2: 69,538,982 (GRCm39) probably null Het
Fgf8 C A 19: 45,730,786 (GRCm39) V80F possibly damaging Het
Fras1 A T 5: 96,891,046 (GRCm39) E2858D probably benign Het
Fshr A T 17: 89,293,529 (GRCm39) L383Q probably damaging Het
Gmeb2 T G 2: 180,897,019 (GRCm39) M290L probably benign Het
Gnptg A G 17: 25,454,828 (GRCm39) probably null Het
Grik2 A C 10: 49,008,871 (GRCm39) S739A probably damaging Het
Grk2 T A 19: 4,337,222 (GRCm39) Q659L probably benign Het
Hdhd5 A G 6: 120,491,473 (GRCm39) V210A probably damaging Het
Hyal1 C T 9: 107,455,091 (GRCm39) L134F probably damaging Het
Itgb2 A T 10: 77,381,987 (GRCm39) K18N possibly damaging Het
Jam3 A T 9: 27,017,701 (GRCm39) I29K possibly damaging Het
Kcnh3 C A 15: 99,137,796 (GRCm39) D830E probably benign Het
Kcnmb4 T C 10: 116,309,203 (GRCm39) D75G possibly damaging Het
Kdm4b A G 17: 56,707,025 (GRCm39) Y981C probably damaging Het
Klk1b26 C A 7: 43,665,810 (GRCm39) D207E probably benign Het
Kmt2a G T 9: 44,759,563 (GRCm39) T762N probably benign Het
Kmt2d A G 15: 98,742,819 (GRCm39) probably benign Het
Lama4 T C 10: 38,964,876 (GRCm39) S1414P possibly damaging Het
Lce1f C G 3: 92,626,276 (GRCm39) C127S unknown Het
Map7d1 A G 4: 126,128,558 (GRCm39) probably null Het
Ninl T C 2: 150,822,096 (GRCm39) D2G possibly damaging Het
Or2w1b T A 13: 21,300,303 (GRCm39) M147K probably benign Het
Or5k3 A G 16: 58,969,287 (GRCm39) T25A probably benign Het
Or5m11b C T 2: 85,806,372 (GRCm39) P262S possibly damaging Het
Or6n1 T A 1: 173,916,813 (GRCm39) L69* probably null Het
Or8g18 G C 9: 39,149,547 (GRCm39) P58A probably benign Het
Pax8 A G 2: 24,319,608 (GRCm39) Y381H possibly damaging Het
Pde7a T C 3: 19,314,408 (GRCm39) I63V possibly damaging Het
Pgm3 A T 9: 86,452,340 (GRCm39) F40Y probably benign Het
Phrf1 G T 7: 140,836,564 (GRCm39) D78Y probably damaging Het
Plekhg1 C T 10: 3,890,538 (GRCm39) probably benign Het
Prss59 A T 6: 40,898,652 (GRCm39) S199T probably benign Het
Pum1 T C 4: 130,446,567 (GRCm39) S209P probably damaging Het
Qtrt2 A T 16: 43,689,337 (GRCm39) F220L probably benign Het
Rgs9 A G 11: 109,159,747 (GRCm39) probably null Het
Rin3 A G 12: 102,335,018 (GRCm39) T230A unknown Het
Ros1 A T 10: 51,974,773 (GRCm39) V1604E possibly damaging Het
Rpp14 A G 14: 8,090,528 (GRCm38) M151V probably benign Het
Sacs T A 14: 61,451,153 (GRCm39) F4400I possibly damaging Het
Scamp1 C T 13: 94,361,437 (GRCm39) V148I probably benign Het
Slc13a5 A G 11: 72,141,557 (GRCm39) C428R probably damaging Het
Slc43a2 T G 11: 75,453,733 (GRCm39) probably null Het
Smarcc2 T A 10: 128,299,741 (GRCm39) N135K probably damaging Het
Snx15 G C 19: 6,172,094 (GRCm39) S116R probably damaging Het
Stag1 A G 9: 100,737,885 (GRCm39) E414G possibly damaging Het
Stag1 A T 9: 100,769,426 (GRCm39) probably benign Het
Tmem106a T A 11: 101,481,263 (GRCm39) L257Q possibly damaging Het
Tnc C T 4: 63,882,991 (GRCm39) D1968N probably benign Het
Trim42 A G 9: 97,248,138 (GRCm39) L186P possibly damaging Het
Tshb T A 3: 102,685,624 (GRCm39) probably benign Het
Ttn T A 2: 76,584,484 (GRCm39) D13881V probably damaging Het
Uqcrc2 T C 7: 120,239,506 (GRCm39) V56A probably benign Het
Uty G A Y: 1,197,228 (GRCm39) T113I probably damaging Het
Vps13c A G 9: 67,864,787 (GRCm39) E3032G probably benign Het
Wfdc9 T G 2: 164,493,729 (GRCm39) probably benign Het
Zc3h7a G A 16: 10,980,520 (GRCm39) T31I probably damaging Het
Zfp462 T C 4: 55,060,046 (GRCm39) S1191P probably damaging Het
Other mutations in Glb1
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01448:Glb1 APN 9 114,279,745 (GRCm39) splice site probably benign
IGL01649:Glb1 APN 9 114,253,016 (GRCm39) missense probably damaging 1.00
IGL01720:Glb1 APN 9 114,249,573 (GRCm39) critical splice donor site probably null
IGL02199:Glb1 APN 9 114,303,015 (GRCm39) missense probably benign 0.06
IGL02613:Glb1 APN 9 114,293,130 (GRCm39) missense possibly damaging 0.91
IGL03392:Glb1 APN 9 114,259,389 (GRCm39) missense probably damaging 1.00
R0463:Glb1 UTSW 9 114,250,812 (GRCm39) frame shift probably null
R0518:Glb1 UTSW 9 114,250,812 (GRCm39) frame shift probably null
R0519:Glb1 UTSW 9 114,250,812 (GRCm39) frame shift probably null
R0520:Glb1 UTSW 9 114,250,812 (GRCm39) frame shift probably null
R1387:Glb1 UTSW 9 114,249,431 (GRCm39) missense probably damaging 1.00
R1898:Glb1 UTSW 9 114,253,103 (GRCm39) missense probably damaging 1.00
R2143:Glb1 UTSW 9 114,266,892 (GRCm39) missense probably damaging 1.00
R2145:Glb1 UTSW 9 114,293,233 (GRCm39) missense probably benign 0.00
R2146:Glb1 UTSW 9 114,279,716 (GRCm39) missense probably damaging 1.00
R2148:Glb1 UTSW 9 114,279,716 (GRCm39) missense probably damaging 1.00
R2149:Glb1 UTSW 9 114,279,716 (GRCm39) missense probably damaging 1.00
R2150:Glb1 UTSW 9 114,279,716 (GRCm39) missense probably damaging 1.00
R2170:Glb1 UTSW 9 114,302,873 (GRCm39) critical splice acceptor site probably benign
R2259:Glb1 UTSW 9 114,272,100 (GRCm39) nonsense probably null
R2401:Glb1 UTSW 9 114,283,325 (GRCm39) missense possibly damaging 0.81
R3980:Glb1 UTSW 9 114,246,132 (GRCm39) missense probably damaging 0.97
R4488:Glb1 UTSW 9 114,272,182 (GRCm39) missense probably damaging 1.00
R4696:Glb1 UTSW 9 114,293,220 (GRCm39) missense probably benign
R5349:Glb1 UTSW 9 114,263,529 (GRCm39) critical splice donor site probably null
R6045:Glb1 UTSW 9 114,267,010 (GRCm39) missense probably damaging 1.00
R6448:Glb1 UTSW 9 114,263,499 (GRCm39) missense probably damaging 0.99
R7308:Glb1 UTSW 9 114,302,931 (GRCm39) missense probably damaging 0.98
R7327:Glb1 UTSW 9 114,246,126 (GRCm39) missense probably benign 0.00
R7492:Glb1 UTSW 9 114,303,017 (GRCm39) missense probably damaging 1.00
R8087:Glb1 UTSW 9 114,259,483 (GRCm39) missense probably damaging 1.00
R8181:Glb1 UTSW 9 114,259,429 (GRCm39) missense probably damaging 1.00
R9067:Glb1 UTSW 9 114,302,922 (GRCm39) missense probably damaging 0.99
R9187:Glb1 UTSW 9 114,302,991 (GRCm39) missense probably damaging 1.00
R9289:Glb1 UTSW 9 114,249,558 (GRCm39) missense probably damaging 1.00
R9315:Glb1 UTSW 9 114,285,548 (GRCm39) missense probably benign
R9777:Glb1 UTSW 9 114,246,084 (GRCm39) missense probably damaging 1.00
X0052:Glb1 UTSW 9 114,302,873 (GRCm39) critical splice acceptor site probably benign
Z1177:Glb1 UTSW 9 114,249,490 (GRCm39) missense probably damaging 0.98
Predicted Primers PCR Primer
(F):5'- AGATAGCCTCCTCCACATCACCTTG -3'
(R):5'- GCTTCGCTCTCTTTAGAAAGGCCAG -3'

Sequencing Primer
(F):5'- AAAGGTTCACGTTCTCACGG -3'
(R):5'- TCTCTTTAGAAAGGCCAGTCAAACTC -3'
Posted On 2014-04-13